Patents by Inventor Andrew A. Young

Andrew A. Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190354174
    Abstract: A method for updating information for a graphics pipeline including executing in the first frame period an application on a CPU to generate primitives of a scene for a first video frame. Gaze tracking information is received in a second frame period for an eye of a user. In the second frame period a landing point on an HMD display is predicted at the CPU based at least on the gaze tracking information. A late update of the predicted landing point to a buffer accessible by the GPU is performed in the second frame period. Shader operations are performed in the GPU in the second frame period to generate pixel data based on the primitives and based on the predicted landing point, wherein the pixel data is stored into a frame buffer. The pixel data is scanned out in the third frame period from the frame buffer to the HMD.
    Type: Application
    Filed: May 17, 2018
    Publication date: November 21, 2019
    Inventors: Andrew Young, Javier Fernandez Rico
  • Publication number: 20190354173
    Abstract: A method for predicting eye movement in a head mounted display (HMD). The method including tracking movement of an eye of a user with a gaze tracking system disposed in the HMD at a plurality of sample points. The method including determining velocity of the movement based on the movement of the eye. The method including determining that the eye of the user is in a saccade upon the velocity reaching a threshold velocity. The method including predicting a landing point on the display of the HMD corresponding to a direction of the eye for the saccade.
    Type: Application
    Filed: May 17, 2018
    Publication date: November 21, 2019
    Inventors: Andrew Young, Javier Fernandez Rico
  • Publication number: 20190346922
    Abstract: Gaze tracking data may be analyzed to determine the onset and duration of a vision interrupting event, such as a blink or saccade. Presentation of images to a viewer may then be suspended during the vision interrupting event and resumed in sufficient time to ensure that the viewer sees the image at the time the vision interrupting event has concluded.
    Type: Application
    Filed: July 26, 2019
    Publication date: November 14, 2019
    Inventors: Andrew Young, Jeffrey Roger Stafford
  • Patent number: 10473237
    Abstract: A push rack pipe pusher having a base. A first frame coupled to the base. A second frame coupled to the base. A first pressurized cylinder coupled to the base. A second pressurized cylinder coupled to the base. A third pressurized cylinder coupled to the base. A fourth pressurized cylinder coupled to the base. A lower track conveyer system coupled to the base and positioned between the first frame and the second frame. An upper track conveyer system coupled to the pressurized cylinders and positioned between the first frame and the second frame. A control unit coupled to the upper track conveyer system, the lower track conveyer system, and the pressurized cylinders.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: November 12, 2019
    Assignee: Broussard Brothers Inc.
    Inventors: Noah Raywood Broussard, III, Frank Andrew Young
  • Publication number: 20190325634
    Abstract: A method for implementing a graphics pipeline. The method includes generating a system of particles creating an effect in a virtual scene, the system of particles comprising a plurality of particle geometries. The method includes determining a subsystem of particles from the system of particles, the subsystem of particles comprising a subset of particle geometries taken from the plurality of particle geometries. The method includes determining a foveal region when rendering an image of the virtual scene, wherein the foveal region corresponds to where an attention of a user is directed. The method includes determining that at least one portion of the effect is located in the peripheral region for the image. The method includes rendering the subsystem of particles to generate the effect.
    Type: Application
    Filed: July 2, 2019
    Publication date: October 24, 2019
    Inventors: Andrew Young, Chris Ho, Jeffrey Roger Stafford
  • Patent number: 10401952
    Abstract: Gaze tracking data may representing a user's gaze with respect to one or more images transmitted to a user are analyzed to determine one or more regions of interest. Compression of the one or more transmitted images is adjusted so that fewer bits are needed to transmit data for portions of an image outside the one or more regions interest than for portions of the image within the one or more regions of interest.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: September 3, 2019
    Assignee: SONY INTERACTIVE ENTERTAINMENT INC.
    Inventors: Andrew Young, Jeffrey Roger Stafford
  • Publication number: 20190247390
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions.
    Type: Application
    Filed: February 14, 2019
    Publication date: August 15, 2019
    Inventors: Bronislava GEDULIN, Andrew A. YOUNG, Howard E. GREENE
  • Patent number: 10372205
    Abstract: Gaze tracking data may be analyzed to determine the onset and duration of a vision interrupting event, such as a blink or saccade. Presentation of images to a viewer may then be suspended during the vision interrupting event and resumed in sufficient time to ensure that the viewer sees the image at the time the vision interrupting event has concluded.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: August 6, 2019
    Assignee: SONY INTERACTIVE ENTERTAINMENT INC.
    Inventors: Andrew Young, Jeffrey Roger Stafford
  • Patent number: 10339692
    Abstract: A method for implementing a graphics pipeline. The method includes generating a system of particles creating an effect in a virtual scene, the system of particles comprising a plurality of particle geometries. The method includes determining a subsystem of particles from the system of particles, the subsystem of particles comprising a subset of particle geometries taken from the plurality of particle geometries. The method includes determining a foveal region when rendering an image of the virtual scene, wherein the foveal region corresponds to where an attention of a user is directed. The method includes determining that at least one portion of the effect is located in the peripheral region for the image. The method includes rendering the subsystem of particles to generate the effect.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: July 2, 2019
    Assignee: Sony Interactive Entertainment Inc.
    Inventors: Andrew Young, Chris Ho, Jeffrey Roger Stafford
  • Patent number: 10288619
    Abstract: A method for diagnosing an increased risk of a cancer in a subject includes the steps of obtaining a blood sample from the subject and determining, in the blood sample, a level of two or more of the polypeptides selected from the group consisting of VNN2, KCNJ15, SERPINB2, CREB5, ICAM3, NFE2, MNDA, PXN, FCAR, TSHZ3, NRG1, ALOX5AP, PAD14, PAD12, QPC, VNN1, SERPINB10, CLEC4D, TREM1, CLEC4E, CD82, MGAM, TMEM45B and VNN3, wherein an increase in the level of two or more of the polypeptides compared to a control level is indicative of an increased risk of cancer in the subject.
    Type: Grant
    Filed: June 24, 2015
    Date of Patent: May 14, 2019
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventors: Kevin D. Cooper, Thomas S. McCormick, David S. Soler, Andrew Young
  • Patent number: 10287608
    Abstract: Provided herein are compositions and methods for selective expression of a transgene. Compositions and methods for selective expression of a transgene comprise one or more human regulatory elements, which, when operably linked to a transgene, can facilitate selective expression of a transgene (e.g., cell-type selective expression) in a target cell as compared to at least one or more non-target cells.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: May 14, 2019
    Assignee: Encoded Therapeutics, Inc.
    Inventors: Stephanie Tagliatela, Andrew Young, Szu-Ying Chen, Kartik Ramamoorthi, David Oberkofler
  • Patent number: 10287607
    Abstract: Provided herein are compositions and methods for selective expression of a transgene. Compositions and methods for selective expression of a transgene comprise one or more human regulatory elements, which, when operably linked to a transgene, can facilitate selective expression of a transgene (e.g., cell-type selective expression) in a target cell as compared to at least one or more non-target cells.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: May 14, 2019
    Assignee: Encoded Therapeutics, Inc.
    Inventors: Stephanie Tagliatela, Andrew Young, Szu-Ying Chen, Kartik Ramamoorthi, David Oberkofler
  • Publication number: 20190136765
    Abstract: A durable light weight, high temperature acoustic CMC liner system. A thin ceramic matrix composite skin, also referred to as a facesheet, forms an outer layer of a cell in the CMC liner system, forming the boundary with the flow of hot gases in the exhaust. A backplate forms the opposite boundary for the cell. The truss structure is formed between the backplate and the facesheet and provides the cell with strength. When the CMC system replaces the metal liner, the backplate thickness is increased so that it is about the thickness of the liner system that it replaces. The truss structure extends between the backplate and the facesheet, forming channels or volumetric spaces. These channels or volumetric spaces are filled with high temperature air permeable acoustic materials that attenuate sound propagated by cooling air in the acoustic range.
    Type: Application
    Filed: November 9, 2017
    Publication date: May 9, 2019
    Inventors: Geoffrey Eric FAIR, Craig Douglas YOUNG, Kevin Andrew YOUNG
  • Patent number: 10251880
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: April 9, 2019
    Assignee: SATIOGEN PHARMACEUTICALS, INC.
    Inventors: Bronislava Gedulin, Andrew A. Young, Howard E. Greene
  • Patent number: 10192528
    Abstract: Foveated rendering based on user gaze tracking may be adjusted to account for the realities of human vision. Gaze tracking error and state parameters may be determined from gaze tracking data representing a user's gaze with respect to one or more images presented to a user. Adjusted foveation data representing an adjusted size and/or shape of one or more regions of interest in one or more images to be subsequently presented to a user may be generated based on the one or more gaze tracking error or state parameters. Foveated image data representing one or more foveated images may be generated with the adjusted foveation data. The foveated images are characterized by level of detail within the one or more regions of interest and lower level of detail outside the one or more regions of interest. The foveated images may then be presented to the user.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: January 29, 2019
    Assignee: Sony Interactive Entertainment Inc.
    Inventors: Andrew Young, Jeffrey Roger Stafford
  • Patent number: 10188646
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions.
    Type: Grant
    Filed: February 22, 2012
    Date of Patent: January 29, 2019
    Assignee: SATIOGEN PHARMACEUTICALS, INC.
    Inventors: Bronislava Gedulin, Andrew A. Young, Howard E. Greene
  • Publication number: 20190024118
    Abstract: Provided herein are compositions and methods for selective expression of a transgene. Compositions and methods for selective expression of a transgene comprise one or more human regulatory elements, which, when operably linked to a transgene, can facilitate selective expression of a transgene (e.g., cell-type selective expression) in a target cell as compared to at least one or more non-target cells.
    Type: Application
    Filed: October 5, 2018
    Publication date: January 24, 2019
    Inventors: Stephanie TAGLIATELA, Andrew YOUNG, Szu-Ying CHEN, Kartik RAMAMOORTHI, David OBERKOFLER
  • Publication number: 20190024121
    Abstract: Provided herein are compositions and methods for selective expression of a transgene. Compositions and methods for selective expression of a transgene comprise one or more human regulatory elements, which, when operably linked to a transgene, can facilitate selective expression of a transgene (e.g., cell-type selective expression) in a target cell as compared to at least one or more non-target cells.
    Type: Application
    Filed: October 5, 2018
    Publication date: January 24, 2019
    Inventors: Stephanie TAGLIATELA, Andrew YOUNG, Szu-Ying CHEN, Kartik RAMAMOORTHI, David OBERKOFLER
  • Publication number: 20190024119
    Abstract: Provided herein are compositions and methods for selective expression of a transgene. Compositions and methods for selective expression of a transgene comprise one or more human regulatory elements, which, when operably linked to a transgene, can facilitate selective expression of a transgene (e.g., cell-type selective expression) in a target cell as compared to at least one or more non-target cells.
    Type: Application
    Filed: October 5, 2018
    Publication date: January 24, 2019
    Inventors: Stephanie Tagliatela, Andrew Young, Szu-Ying Chen, Kartik Ramamoorthi, David Oberkofler
  • Patent number: D849623
    Type: Grant
    Filed: October 4, 2016
    Date of Patent: May 28, 2019
    Assignee: The Boeing Company
    Inventors: Paul Joseph Wilcynski, David Andrew Young